Antithrombotic Therapy to Ameliorate Clinical Complications of Community Acquired Pneumonia
Winnipeg, Manitoba
Joined October 2020
- Tweets77
- Following53
- Followers345
- Likes162
ATTACC CAP retweeted
Winnipeg-based research project testing out pneumonia treatment winnipeg.ctvnews.ca/winnipeg…
ATTACC CAP retweeted
Congrats to the UM team awarded $6.9 million by the @CIHR_IRSC to lead an international trial of a steroid drug for pneumonia. The grant will enable expansion of a network of hospital-ward research sites, helping Canada prepare for future pandemics. news.umanitoba.ca/um-team-re…
ATTACC CAP retweeted
Today, Minister of Health Mark Holland announced a $43M investment in 14 new Canadian-led #ClinicalTrials to assess treatments and tools with the potential to save lives.
canada.ca/en/institutes-heal…
ALT Results: Clinical Trials Projects
We are so excited to expand ATTACC-CAP to include corticosteroids with the introduction of the newly funded DEFEND-CAP domain!
Exciting news! UM team receives $6.9 million to test pneumonia treatment and expand the network of research sites. Find out more at news.umanitoba.ca/um-team-re…
#UManitoba #UMResearch
Such an exciting milestone!
200 patients enrolled in ATTACC-CAP!!
💯 💯
Thanks to all our patient participants, their families, our sites, investigators, coordinators, and large number of partners!
@ATTACC_CAP
ATTACC CAP retweeted
200 patients enrolled in ATTACC-CAP!!
💯 💯
Thanks to all our patient participants, their families, our sites, investigators, coordinators, and large number of partners!
@ATTACC_CAP
ATTACC CAP retweeted
We are pleased to announce an investment
of $500K allocated over 5 years designated to support the ATTACC-CAP trail led by @umanitoba researcher @RZarychanski, this will be the second-largest clinical trial led out of Manitoba.
Read full news release: bit.ly/44gf40Q
ATTACC CAP retweeted
Thanks to @N2Canada for creating this infographic all about #InternationalClinicalTrialsDay!
ATTACC CAP retweeted
Honored to be recognized as @DoctorsManitoba top 40 under 40! This represents the efforts of a large research team - through COVID and now beyond…. It’s thanks to a productive and enabling team and mentors that we can innovate in medicine, for the benefits of our patients.
Our next phase of ATTACC, ATTACC-CAP, has been generously funded by @Research_MB! Congratulations to our Manitoba PIs @RZarychanski and @sylvainlother
We are pleased to announce an investment
of $500K allocated over 5 years designated to support the ATTACC-CAP trail led by @umanitoba researcher @RZarychanski, this will be the second-largest clinical trial led out of Manitoba.
Read full news release: bit.ly/44gf40Q
ATTACC PI Dr. Ryan Zarychanski is being recognized as Doctors Manitoba Physician of the Year. Congratulations @RZarychanski! We look forward to your leadership in the next chapter of the ATTACC trial.
Physician of the Year, Dr. Ryan Zarychanski is being recognized for his truly groundbreaking work leading world-wide efforts to rapidly identify effective COVID-19 treatments. @RZarychanski
ATTACC CAP retweeted
Thanks to the authors of these 6 high quality RCTs we were able to document that full anticoagulation is improving survival in non-critically-ill #covid19
Swiss COVID-HEP
#PROTHROMCOVID
@ATTACC_COVID
@ACTIV4a
@remap_cap
#RAPIDtrial
@CovidHep
BEMICOP
🔗 link.springer.com/article/10…
⬇️ Important summary on the use of antithrombotic agents in patients with COVID-19
🆕 In our @CMAJ paper published today, @TritschlerMD @RZarychanski and I summarize 5 key things to know about antithrombotics in #COVID19.
cmaj.ca/content/194/20/E704
@remap_cap @ACTIV4a @RZarychanski @PatrickLawlerMD @ecgoligher @um_research @UM_RadyFHS @UHN_Research
ATTACC CAP retweeted
🔥 This week we'll be discussing the hot topic of VTE Prophylaxis in COVID-19
‼️ Our latest protocol is published on Ask Mayo Expert (AME): mayocl.in/35QZcJu
Go to Inpatient management (adult) ➡️ Inpatient care ➡️ COVID-19 VTE Prophylaxis in Hospitalized Patients
ATTACC CAP retweeted
Practice changing work from the #mpRCT and efforts of @ACTIV4a @ATTACC_COVID @remap_cap. @nih_nhlbi @NIH guidelines recommending therapeutic heparin for moderately ill hospitalized patients with #Covid_19 based on our @NEJM papers @NIHCOVIDTxGuide @UPMC @PittTweet
Breaking news on #Covid_19 treatment from @nih_nhlbi!
A recommendation for full anticoagulation with low molecular weight heparin for hospitalized patients. Please spread the word!
bit.ly/3n1sZF8
ATTACC CAP retweeted
A step forward - therapeutic LWMH recommended for hospitalized non-critically I’ll patients with COVID19 @PatrickLawlerMD @ecgoligher @ATTACC_COVID @remap_cap @ACTIV4a @CritCareReviews @accpchest @WHO
ATTACC CAP retweeted
@ecgoligher @PatrickLawlerMD and @RZarychanski present the results of the ATTACC trial, platform trials and the global collaboration involved @CCCForum #CCCF2021 with @JohnGranton1 and @charlot_summers
ATTACC CAP retweeted
#CCCF2021
Keynote address
Monday December 6, 4:45pm
Anticoagulation in COVID-19
by @RZarychanski @ecgoligher @PatrickLawlerMD
criticalcarecanada.com
ATTACC CAP retweeted
Superb @UofT_DoM Grand Rounds by @ecgoligher & @PatrickLawlerMD on the background, statistical approach & interpretation of the adaptive Bayesian design multiplatform @ATTACC_COVID / @ACTIV4a / @remap_cap anticoag in COVID trial.
nejm.org/doi/full/10.1056/NE…
nejm.org/doi/full/10.1056/NE…
